{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["20(9)"],"submitter":["Chen X"],"pubmed_abstract":["<h4>Background</h4>Minimally invasive transforaminal lumbar interbody fusion (Mis-TLIF) is one of the most commonly used methods for lumbar fusion. However, in recent years, the unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) has also gradually attracted the attention of spine surgeons. This study aims to compare the perioperative and long-term clinical outcomes of the two procedures for lumbar degenerative diseases (LDD).<h4>Methods</h4>We collected clinical data of patients who had undergone minimally invasive transforaminal lumbar interbody fusion (Mis-TLIF) or unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) for lumbar degenerative diseases (LDD) from January 2019 to December 2022. The primary outcome measure was the Oswestry Disability Index (ODI) at 1"],"journal":["PloS one"],"pagination":["e0333165"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12468841"],"repository":["biostudies-literature"],"pubmed_title":["Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a retrospective multicenter cohort study."],"pmcid":["PMC12468841"],"pubmed_authors":["Liu Y","Shi L","Zhang Z","Xie J","Chen X","Hu L"],"additional_accession":[]},"is_claimable":false,"name":"Unilateral biportal endoscopic lumbar interbody fusion versus minimally invasive transforaminal lumbar interbody fusion in the treatment of lumbar degenerative diseases: a retrospective multicenter cohort study.","description":"<h4>Background</h4>Minimally invasive transforaminal lumbar interbody fusion (Mis-TLIF) is one of the most commonly used methods for lumbar fusion. However, in recent years, the unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) has also gradually attracted the attention of spine surgeons. This study aims to compare the perioperative and long-term clinical outcomes of the two procedures for lumbar degenerative diseases (LDD).<h4>Methods</h4>We collected clinical data of patients who had undergone minimally invasive transforaminal lumbar interbody fusion (Mis-TLIF) or unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) for lumbar degenerative diseases (LDD) from January 2019 to December 2022. The primary outcome measure was the Oswestry Disability Index (ODI) at 1","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-05-01T03:19:31.837Z","creation":"2026-05-01T03:11:06.377Z"},"accession":"S-EPMC12468841","cross_references":{"pubmed":["41004447"],"doi":["10.1371/journal.pone.0333165"]}}